Tumor molecular profiling

OTHER3 trials

Sponsors

Hellenic Cooperative Oncology Group

Conditions

Epithelial Ovarian CancerGermline BRCA1 Gene MutationGermline BRCA2 Gene MutationMetastatic Prostate AdenocarcinomaMutationProstate CancerProstate Cancer MetastaticProstate Cancer Recurrent

Unknown Phase

Pathogenic Variants in Homologous Recombination Repair Genes in Patients With Epithelial Ovarian Cancer

CompletedNCT04716374

Hellenic Cooperative Oncology GroupEpithelial Ovarian Cancer

Start: 2004-01-31End: 2019-12-31Updated: 2021-01-20

Molecular Profiling in Prostate Cancer

Hellenic Cooperative Oncology GroupGermline BRCA1 Gene Mutation, Germline BRCA2 Gene Mutation, Mutation +2

Start: 2020-10-01End: 2023-08-01Updated: 2023-03-01

Tumor Molecular Profiling in Patients With Prostate Cancer

CompletedNCT05573789

Hellenic Cooperative Oncology GroupMetastatic Prostate Adenocarcinoma, Prostate Cancer

Start: 2018-01-01End: 2022-09-01Updated: 2022-10-19

Related Papers

Tumor Genotyping and Homologous Recombination Repair Gene Variants in Patients With Epithelial Ovarian Cancer: Is Pathogenic Enough?

Frontiers in Oncology2021-06-012 citations